QA-68- and dBRD9-A-induced cell killing correlated with BRD9 degradation, and as observed with AML and ALL, c-MYC expression was variable in response to BRD9 loss in different MM lines (Supplementary Fig. 9D, F). The gene discussed is MYC; the disease is acute lymphoblastic leukemia.